SEC Filing Analysis: COOPER COMPANIES, INC. (COO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Holly R Sheffield, President of CooperSurgical (CSI), received a routine equity grant of 23,881 stock units as part of her compensation package.
• Market Impact: The transaction is a non-market award with negligible immediate market impact or shareholder dilution.

Company Information

Field	Value
Company	COOPER COMPANIES, INC.
Ticker Symbol	COO
CIK	0000711404
Industry	Ophthalmic Goods

Insider Information

Field	Value
Name	Sheffield Holly R
CIK	0001745369
Title/Position	President, CSI
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-09
Transaction Code	A (Grant)
Security Type	Performance Stock Units & Restricted Stock Units
Shares Involved	23,881
Price Per Share	$0.00
Total Value	$0
Shares Owned After	23,881 (of these specific derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	23,881
% of Shares Outstanding	0.012%
Post-Transaction Ownership	23,881 derivative shares (<0.02% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $14.34 billion, this grant is a standard operational expense related to executive compensation and is not financially material.
• Dilution Impact: The grant of 23,881 shares represents a potential dilution of approximately 0.012% of the 198.8 million shares outstanding. This level of dilution is minimal and typical for executive equity awards in a large-cap company.
• Transaction Significance: The transaction's significance is low. It is a non-market award (Code A) with a $0 transaction price, indicating it is part of a compensation plan rather than an insider's market sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a standard form of executive compensation and do not reflect an insider's discretionary investment decision. The market typically does not react to such routine filings.

Volume & Sentiment

• Expected Volume Impact: None. This was not an open-market transaction.
• Sentiment Indicator: Neutral. This filing provides insight into the company's compensation structure but is not a bullish or bearish signal.

Additional Context

Transaction Notes

• Special Circumstances: The grant is split between 15,921 Restricted Stock Units (RSUs) vesting over four years and 7,960 Performance Stock Units (PSUs) that vest after a three-year period based on Total Shareholder Return (TSR) performance, with a potential payout between 0% and 200% of the target.